The Novel Profiling Relative Inhibition Simultaneously in Mixtures (PRISM) Platform Identifies Synergistic Activity of Lanraplenib and Ruxolitinib in Hematological MalignanciesAkanksha Pandey,Luis A. Carvajal, Andrew S Boghossian, Matthew G Rees, Melissa M Ronan, Jennifer A Roth,Tressa Hood, Linlin Guo,Tamara D Hopkins,Nikolaus Obholzer,Michael R. McKeown,Jorge F. DiMartino,Charles Y. LinBlood（2023）引用 0|浏览1暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
